Unknown

Dataset Information

0

Exposure-Response Analysis of Nivolumab in Patients With Previously Treated or Untreated Advanced Melanoma.

ABSTRACT:

SUBMITTER: Bajaj G 

PROVIDER: S-EPMC5697692 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Exposure-Response Analysis of Nivolumab in Patients With Previously Treated or Untreated Advanced Melanoma.

Bajaj Gaurav G   Gupta Manish M   Feng Yan Y   Statkevich Paul P   Roy Amit A  

Journal of clinical pharmacology 20170811 12

Similar Datasets

Unknown Five-year survival with nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma.
| S-EPMC8252056 | biostudies-literature
Unknown Long-term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma.
| S-EPMC6549931 | biostudies-literature
Unknown Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.
| S-EPMC9844513 | biostudies-literature
Unknown Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial.
| S-EPMC6439558 | biostudies-literature
Unknown Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab.
| S-EPMC9296775 | biostudies-literature
Unknown Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab.
| S-EPMC4517051 | biostudies-literature
Unknown Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression: Analysis of 2 Phase 3 Clinical Trials.
| S-EPMC5710191 | biostudies-literature
Unknown Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis.
| S-EPMC7193685 | biostudies-literature
Unknown Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer.
| S-EPMC9147485 | biostudies-literature
Unknown Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up.
| S-EPMC6978670 | biostudies-literature